U.S. President Donald Trump has signed an executive order aimed at expanding the use of artificial intelligence (AI) in pediatric cancer research. The order provides an additional $50 million in research grants to accelerate progress in finding cures for childhood cancers, according to White House officials.
This move builds on the National Cancer Institute’s (NCI) Childhood Cancer Data Initiative, a decade-long, $500 million program launched in 2019 to collect and share vital data on pediatric cancers. Michael Kratsios, director of the White House Office of Science and Technology Policy, highlighted that childhood cancer remains the leading cause of disease-related deaths among children in the United States, with cases rising more than 40% since 1975.
Kratsios noted that advances in AI can now be harnessed to sharpen diagnoses, improve clinical trials, fine-tune treatment strategies, and enhance prevention methods. Data gathered through the NCI initiative is expected to empower researchers with new tools to tackle the complexity and diversity of pediatric cancers.
In addition to the $50 million in grants, the National Institutes of Health (NIH) will double its commitment by investing another $50 million. This funding aims to attract leading scientific teams through competitive research opportunities. Further investments are also anticipated to strengthen ongoing initiatives.
The announcement comes despite Trump’s 2026 budget proposal, which suggested a 37% cut to the NCI budget. Lawmakers in both the House and Senate, however, have pushed back against these cuts, and budget negotiations remain ongoing.
Globally, the World Health Organization reports that around 400,000 children and adolescents are diagnosed with cancer each year. While advances in adult cancer research have surged with AI, pediatric cancer research has lagged due to challenges like cancer rarity, diversity, and ethical concerns over patient data protection.
By reinforcing funding and leveraging AI, the administration aims to close this gap and accelerate life-saving innovations in childhood cancer treatment.


Trump and Merck KGaA Partner to Slash IVF Drug Costs and Expand Fertility Coverage
China Approves First Import Batch of Nvidia H200 AI Chips Amid Strategic Shift
SpaceX Starship Explodes in Texas During Test, Citing Nitrogen Tank Failure
California Governor Gavin Newsom Launches Review Into Alleged TikTok Content Suppression After U.S. Ownership Deal
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
Mark Carney Walks Back Davos Remarks After Call With Donald Trump, Says U.S. Treasury Secretary
ByteDance Finalizes Majority U.S.-Owned TikTok Joint Venture to Avert American Ban
Trump Administration Gun Comments Spark Rift With NRA Ahead of Midterms
Japan Urges Fishermen to Avoid Senkaku Islands as China Tensions Rise
Colombia Launches $1.68 Billion Anti-Drone Shield to Counter Armed Groups
Japan Signals Readiness to Act on Yen Volatility Amid U.S. Coordination Talks
Lost in space: MethaneSat failed just as NZ was to take over mission control – here’s what we need to know now
NASA Resumes Cygnus XL Cargo Docking with Space Station After Software Fix
Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies
California Attorney General Orders xAI to Halt Illegal Grok Deepfake Imagery 



